Literature DB >> 14552840

T-cell receptor signal transmission: who gives an ITAM?

Lisa A Pitcher1, Nicolai S C van Oers.   

Abstract

T cells have an amazing ability to discern and differentially respond to MHC-embedded peptides that can differ by only a single amino acid. This potential involves a combination of the precise ligand-binding specificities of the T-cell receptor (TCR) and the distinct intracellular signaling processes it transmits. Signaling processes are controlled by the ten immunoreceptor tyrosine-based activation motifs (ITAMs) present in the invariant chains of the TCR complex (TCR zeta and CD3-gamma, -delta and -epsilon ). Here, we discuss recent studies of the functions of TCR invariant chains and the contribution of the ten ITAMs to T-cell signal transmission. We incorporate these results into two non-exclusive models of TCR signal transduction: the ITAM multiplicity model, which describes a functional redundancy within the TCR zeta and CD3 ITAMs; and the differential signaling model, which proposes distinct functions for the CD3-gamma, -delta and -epsilon and TCR zeta modules.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14552840     DOI: 10.1016/j.it.2003.08.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  59 in total

Review 1.  Evolution of immunity: no development without risk.

Authors:  Alexander B Sigalov
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  Cells diversify transmembrane signaling through the controlled chaos of protein disorder.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2011-04-01

3.  Nck adaptors are positive regulators of the size and sensitivity of the T-cell repertoire.

Authors:  Edwige Roy; Dieudonnée Togbe; Amy D Holdorf; Dmitry Trubetskoy; Sabrina Nabti; Günter Küblbeck; Alexandra Klevenz; Annette Kopp-Schneider; Frank Leithäuser; Peter Möller; Friedhelm Bladt; Günter Hämmerling; Bernd Arnold; Tony Pawson; Anna Tafuri
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-13       Impact factor: 11.205

Review 4.  T-cell signaling regulated by the Tec family kinase, Itk.

Authors:  Amy H Andreotti; Pamela L Schwartzberg; Raji E Joseph; Leslie J Berg
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-02       Impact factor: 10.005

5.  Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production.

Authors:  David M Underhill; Eddie Rossnagle; Clifford A Lowell; Randi M Simmons
Journal:  Blood       Date:  2005-06-14       Impact factor: 22.113

6.  Binding of intrinsically disordered proteins is not necessarily accompanied by a structural transition to a folded form.

Authors:  Alexander B Sigalov; Anastasia V Zhuravleva; Vladislav Yu Orekhov
Journal:  Biochimie       Date:  2006-11-22       Impact factor: 4.079

7.  CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson's disease.

Authors:  Rudy J Castellani; Summer L Nugent; Alan L Morrison; Xiongwei Zhu; Hyoung-Gon Lee; Peggy L R Harris; Vladan Bajić; Hari S Sharma; Shu G Chen; Peter Oettgen; George Perry; Mark A Smith
Journal:  J Neural Transm (Vienna)       Date:  2010-10-24       Impact factor: 3.575

8.  Structural characteristics of zebrafish orthologs of adaptor molecules that associate with transmembrane immune receptors.

Authors:  Jeffrey A Yoder; Timothy M Orcutt; David Traver; Gary W Litman
Journal:  Gene       Date:  2007-07-27       Impact factor: 3.688

9.  The proline-rich sequence of CD3epsilon as an amplifier of low-avidity TCR signaling.

Authors:  Pankaj Tailor; Sue Tsai; Afshin Shameli; Pau Serra; Jinguo Wang; Stephen Robbins; Masao Nagata; Andrea L Szymczak-Workman; Dario A A Vignali; Pere Santamaria
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 10.  Organization of proximal signal initiation at the TCR:CD3 complex.

Authors:  Clifford S Guy; Dario A A Vignali
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.